Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Taiga Nishihori"'
Autor:
Miguel-Angel Perales, Soyoung Kim, Roy F. Chemaly, Marcie L. Riches, Randy Taplitz, Ephraim J. Fuchs, Christopher E. Dandoy, Christopher G. Kanakry, Taiga Nishihori, Min Chen, Sagar S. Patel, Stefan O. Ciurea, Anurag K. Singh, Richard T. Maziarz, Hillard M. Lazarus, Jean A. Yared, Maxwell M. Krem, Per Ljungman, Muhammad Bilal Abid, Brian D. Friend, Rizwan Romee, Krishna V. Komanduri, Siddhartha Ganguly, Asad Bashey, Carolyn Mulroney, John R. Wingard, Miguel Pérez, Scott R. Goldsmith
Publikováno v:
Br J Haematol
British journal of haematology, vol 194, iss 1
British journal of haematology, vol 194, iss 1
Community respiratory viral infections (CRVIs) are associated with pulmonary function impairment, alloimmune lung syndromes and inferior survival in human leucocyte antigen (HLA)-matched allogeneic haematopoietic stem cell transplant (HCT) recipients
Autor:
Gabriel De Avila, Steven A. Eschrich, Ariosto S. Silva, Min Liu, David C. Koomen, Mark B. Meads, Timothy J. Garrett, Oliver A. Hampton, Taiga Nishihori, Raghunandan Reddy Alugubelli, Alexandre Tungesvik, Kenneth H. Shain, Dario M. Magaletti, Bin Fang, Paula Oliveira, Zhijie Jiang, Eric A. Welsh, John M. Koomen, Laurel E. Meke, Joy Guingab-Cagmat
Publikováno v:
Journal of Proteome Research. 20:3134-3149
Multiple myeloma is an incurable hematological malignancy that impacts tens of thousands of people every year in the United States. Treatment for eligible patients involves induction, consolidation with stem cell rescue, and maintenance. High-dose th
Autor:
Lia Perez, Joseph Pidala, Jongphil Kim, Michael Nieder, Hany Elmariah, Rawan Faramand, Hien D. Liu, Aleksandr Lazaryan, Claudio Anasetti, Asmita Mishra, Syeda Mahrukh Hussnain Naqvi, Nelli Bejanyan, Farhad Khimani, Taiga Nishihori
Publikováno v:
Bone Marrow Transplantation. 56:1683-1690
Higher infused total nucleated cell dose (TNC) in allogeneic bone marrow transplant (BMT) with post-transplant cyclophosphamide (PTCy) is associated with improved overall survival. As many centers prefer peripheral blood stem cell grafts (PBSCT) with
Autor:
Reena Jayani, Heather S.L. Jim, Yvelise Rodriguez, Gabriel S Krivenko, Bijal D. Shah, Muneer H. Abidi, Brian W James, Julio C. Chavez, Michael D. Jain, Anna Barata, Margaret Booth-Jones, Nathaly Irizarry-Arroyo, Javier Pinilla-Ibarz, Christina A Bachmeier, Kelly A. Hyland, Hien D. Liu, Farhad Khimani, Taiga Nishihori, Aasha I. Hoogland, Frederick L. Locke, Aleksandr Lazaryan, Aaron Collier
Publikováno v:
Cancer Medicine, Vol 10, Iss 6, Pp 1936-1943 (2021)
Cancer Medicine
Cancer Medicine
Chimeric antigen receptor T‐cell therapy with axicabtagene ciloleucel (axi‐cel) has considerably improved survival in adults with relapsed/refractory large B‐cell lymphoma. This study reports patient‐reported outcomes (PROs) such as quality o
Autor:
Wael Saber, Ann E. Woolfrey, Tamila L. Kindwall-Keller, Uday R. Popat, Melhem Solh, Mahmoud Aljurf, Robert Peter Gale, Ryotaro Nakamura, Taiga Nishihori, Bipin N. Savani, Mark R. Litzow, Amer Beitinjaneh, Rammurti T. Kamble, Richard F. Olsson, Sachiko Seo, Jean A. Yared, Jeff Szer, Jane L. Liesveld, Usama Gergis, Betty K. Hamilton, Zhen-Huan Hu, Siddhartha Ganguly, Jan Cerny, Soyoung Kim, Jean-Yves Cahn, Edward A. Copelan, Edwin P. Alyea, Leo F. Verdonck, Biju George, Shahrukh K. Hashmi, Shahinaz M. Gadalla, Aaron T. Gerds, Ying Liu, Bart L. Scott, Gerhard C. Hildebrandt, Baldeep Wirk, Vikas Gupta, Ronald Sobecks, Richard T. Maziarz, Hillard M. Lazarus, David A. Rizzieri, Ulrike Bacher
Publikováno v:
Blood Advances. 4:4748-4757
Comparative outcomes of allogeneic hematopoietic cell transplantation (HCT) for BCR-ABL1− myeloproliferative neoplasms (MPNs) in blast phase (MPN-BP) vs de novo acute myeloid leukemia (AML), and AML with prior myelodysplastic syndromes (MDSs; post-
Autor:
Asmita Mishra, Hiroshi Kotani, Ricardo J. Gonzalez, Michael D. Jain, Biwei Cao, Marco L. Davila, Mohammad Hussaini, Rawan Faramand, Claudio Anasetti, Kayla Reid, John E. Mullinax, Bijal D. Shah, Javier Pinilla, Christina A Bachmeier, Aleksandr Lazaryan, Julio C. Chavez, Renyuan Bai, Sae Bom Lee, Farhad Khimani, Brigett Brandjes, Taiga Nishihori, Verena Staedtke, Frederick L. Locke, Xuefeng Wang, Marian Dam, Kristen Spitler
Publikováno v:
Clin Cancer Res
Purpose:One of the challenges of adoptive T-cell therapy is the development of immune-mediated toxicities including cytokine release syndrome (CRS) and neurotoxicity (NT). We aimed to identify factors that place patients at high risk of severe toxici
Autor:
Anuhya Kommalapati, Julio C. Chavez, Marco L. Davila, Abu-Sayeef Mirza, Christina A Bachmeier, Frederick L. Locke, Hamza Hashmi, Javier Pinilla-Ibarz, Hien D. Liu, Franco Garcia, Rahul Mhaskar, Constantine Logothetis, Aleksandr Lazaryan, Michael D. Jain, Farhad Khimani, Taiga Nishihori, Bijal D. Shah, Alicia Darwin
Publikováno v:
Blood Adv
Key Points VTE developed in 11% of lymphoma patients after CAR T-cell therapy and was managed safely with anticoagulation. Coagulation abnormalities after CAR T-cell therapy occur but do not commonly lead to bleeding events.
Autor:
Siddhartha Ganguly, Andrew Daly, Tracey A. O'Brien, Melhem Solh, Steven Z. Pavletic, Rammurti T. Kamble, Leslie Lehmann, Tao Wang, Takanori Teshima, Amer Beitinjaneh, Miguel Pérez, Mahmoud Aljurf, Mukta Arora, John L. Wagner, Medhat Askar, Marjolein van der Poel, Madan Jagasia, Rabi Hanna, Alvaro Urbano-Ispizua, Ravi Vij, Armin Rashidi, Taiga Nishihori, Catherine J. Lee, A. Samer Al-Homsi, Vijaya Raj Bhatt, Michael T. Hemmer, Roger Strair, Hannah Choe, Joseph Pidala, Jeffery J. Auletta, Hisham Abdel-Azim, Vaibhav Agrawal, Shahinaz M. Gadalla, Stefan O. Ciurea, S Spellman, Margaret L. MacMillan, Rodrigo Martino, Jean-Yves Cahn, Mitchell S. Cairo, Basem M. William, Rizwan Romee, Jean A. Yared, Navneet S. Majhail, Annie Im, Usama Gergis, Mohamed A. Kharfan-Dabaja, Richard F. Olsson, Sagar S. Patel, Baldeep Wirk, Peiman Hematti, Michael Byrne, Asad Bashey, Hemant S. Murthy, Betty K. Hamilton, Muna Qayed, Pooja Khandelwal, Robert Peter Gale, Saurabh Chhabra, Gerhard C. Hildebrandt, Jan Cerny, Sachiko Seo, Roger H. Herzig, Nosha Farhadfar, Deepesh Lad, Hélène Schoemans, Akshay Sharma, Tim Prestidge, Lazaros J. Lekakis, Daniel J. Weisdorf, Paul Castillo, Miguel-Angel Perales
Publikováno v:
Biol Blood Marrow Transplant
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Biology of Blood and Marrow Transplantation, 26(8), 1459-1468. Elsevier Science
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Biology of Blood and Marrow Transplantation, 26(8), 1459-1468. Elsevier Science
Post-transplant cyclophosphamide (PTCy) has significantly increased the successful use of haploidentical donors with a relatively low incidence of graft-versus-host disease (GVHD). Given its increasing use, we sought to determine risk factors for GVH
Autor:
Ayman Saad, Gregory A. Hale, Richard F. Olsson, Guillermo Garcia-Manero, Jane L. Liesveld, Farhad Ravandi, Kwang Woo Ahn, Sachiko Seo, Jan Cerny, Aaron T. Gerds, Michael R. Grunwald, Rammuriti T. Kamble, Taiga Nishihori, Melhem Solh, Xiao Lin, Srdan Verstovsek, Richard E. Champlin, Bipin N. Savani, Ronald Sobecks, Gorgun Akpek, Edwin P. Alyea, Mark R. Litzow, Celalettin Ustun, Hans C. Lee, Xuelin Huang, Andrew Daly, Mahmoud Aljurf, Ulrike Bacher, Hagop M. Kantarjian, Zachariah DeFilipp, Wael Saber, Jorge E. Cortes, Bei Hu, Tamila L. Kindwall-Keller, Bart L. Scott, Marcos de Lima, Nasheed Hossain, Uday R. Popat, Zhen-Huan Hu, Yoshihiro Inamoto, Mohamed A. Kharfan-Dabaja, David I. Marks, Jack W. Hsu, Rebecca S. S. Tidwell, Baldeep Wirk, Elias Jabbour
Publikováno v:
Leukemia & Lymphoma. 61:2811-2820
While TKI are the preferred first-line treatment for chronic phase (CP) CML, alloHCT remains an important consideration. The aim is to estimate residual life expectancy (RLE) for patients initially diagnosed with CP CML based on timing of alloHCT or
Autor:
Narendranath Epperla, Ang Li, Brent Logan, Caitrin Fretham, Saurabh Chhabra, Mahmoud Aljurf, Lynette Chee, Edward Copelan, César O. Freytes, Peiman Hematti, Hillard M. Lazarus, Mark Litzow, Taiga Nishihori, Richard F. Olsson, Tim Prestidge, Wael Saber, Baldeep Wirk, Jean A. Yared, Alison Loren, Marcelo Pasquini, Allistair A. Abraham, Vaibhav Agrawal, Medhat Askar, Pere Barba, Alice Bertaina, Jean‐Yves Cahn, Jan Cerny, Hannah K. Choe, Miguel Angel Diaz, Christopher Dvorak, Nosha Farhadfar, Shahinaz M. Gadalla, Usama Gergis, Siddhartha Ganguly, Shahrukh Hashmi, Kimberly A. Kasow, Sunita Nathan, Roomi Nusrat, Sachiko Seo, Niketa C. Shah
Publikováno v:
British Journal of Haematology. 189:1171-1181
Transplant-associated thrombotic microangiopathy (TA-TMA) is a complication of allogeneic transplantation (allo-HCT). The incidence and risk factors associated with TA-TMA are not well known. A retrospective analysis from the Center for International